Trial NCT04609046

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2020-08331
Secondary IDs: A051901 NCI-2020-08331 U10CA180821

Last trial update was posted on 2024-03-06

MeSH Interventions

Antibodies Antibodies, Monoclonal Antineoplastic Agents, Immunological Immunoglobulins Lenalidomide Methotrexate Nivolumab Rituximab

MeSH Conditions

Lymphoma Lymphoma, Large B-Cell, Diffuse

Other Conditions

Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System

Stopping Reasons

Other - Awaiting amendment approval

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID